Stevanato Group S.p.A.: Stevanato Group Reports Third Quarte

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced

Related Keywords

China , Italy , Indiana , United States , Zhangjiagang , Sichuan , United Kingdom , Italian , Franco Moro , Franco Stevanato , Development Expenses , Exchange Commission On , Company Investor Relations , Stevanato Group , Solutions Segment , Diagnostic Solutions , Engineering Segment , Chief Executive Officer , Diagnostic Solutions Segment , Order Intake , European Time , Financial Information , Investor Relations , States Toll Free , Exchange Commission , Constant Currency Revenue , Adjusted Operating Profit , Adjusted Operating Profit Margin , Adjusted Net Profit , Adjusted Diluted , Capital Employed , Net Cash , Free Cash Flow , Marketing Expenses , Administrative Expenses , Constant Currency , Operating Profit , Income Taxes , Net Profit , Italian Tax , Intangible Assets , Guidance Reported , New Plants , Stevanato , Group , Reports , Third , Quarter , 022 , Financial , Results ,